Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice by unknown
RESEARCH Open Access
Flaxseed oil ameliorates alcoholic liver
disease via anti-inflammation and
modulating gut microbiota in mice
Xiaoxia Zhang1,2, Hao Wang2, Peipei Yin1, Hang Fan1, Liwei Sun1 and Yujun Liu1*
Abstract
Background: Alcoholic liver disease (ALD) represents a chronic wide-spectrum of liver injury caused by
consistently excessive alcohol intake. Few satisfactory advances have been made in management of ALD. Thus,
novel and more practical treatment options are urgently needed. Flaxseed oil (FO) is rich in α-linolenic acid (ALA),
a plant-derived n-3 polyunsaturated fatty acids (PUFAs). However, the impact of dietary FO on chronic alcohol
consumption remains unknown.
Methods: In this study, we assessed possible effects of dietary FO on attenuation of ALD and associated
mechanisms in mice. Firstly, mice were randomly allocated into four groups: pair-fed (PF) with corn oil (CO)
group (PF/CO); alcohol-fed (AF) with CO group (AF/CO); PF with FO group (PF/FO); AF with FO group (AF/FO).
Each group was fed modified Lieber-DeCarli liquid diets containing isocaloric maltose dextrin a control or alcohol
with corn oil and flaxseed oil, respectively. After 6 weeks feeding, mice were euthanized and associated
indications were investigated.
Results: Body weight (BW) was significantly elevated in AF/FO group compared with AF/CO group. Dietary
FO reduced the abnormal elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels
in chronic ethanol consumption. Amelioration of these parameters as well as liver injury via HE staining in
dietary FO supplementation in ALD demonstrated that dietary FO can effectively benefit for the protection
against ALD. To further understand the underlying mechanisms, we investigated the inflammatory cytokine
levels and gut microbiota. A series of inflammatory cytokines, including TNF-α, IL-1β, IL-6 and IL-10, were
determined. As a result, TNF-α, IL-1β and IL-6 were decreased in AF/FO group compared with control group;
IL-10 showed no significant alteration between AF/CO and AF/FO groups (p > 0.05). Sequencing and analysis
of gut microbiota gene indicated that a reduction of Porphyromonadaceae and Parasutterella, as well as an
increase in Firmicutes and Parabacteroides, were seen in AF group compared with PF control. Furthermore,
dietary FO in ethanol consumption group induced a significant reduction in Proteobacteria and
Porphyromonadaceae compared with AF/CO group.
Conclusion: Dietary FO ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota, thus
can potentially serve as an inexpensive interventions for the prevention and treatment of ALD.
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Background
Alcoholic liver disease (ALD) represents a chronic wide-
spectrum of liver injury caused by consistently excessive
alcohol intake, ranking major causes of morbidity and
mortality worldwide among people who abuse alcohol [1].
ALD includes a histological spectrum of liver injure ran-
ging from simple steatosis to hepatitis characterized by in-
flammation, with potential progression to fibrosis and
cirrhosis. Hepatitis, with an occurrence of approximately
10 to 35% in chronic drinkers and responsible for more
than 1/3 significant morbidity and mortality, has been
thought to play a crucial role in reversible pathological
process of ALD [2–4]. Up to now, few satisfactory ad-
vances have been made in management of ALD, except
abstinence from alcohol [4, 5]. Thus, novel and more
practical treatment options are urgently needed.
Gut microbiota play a crucial role in progression and
pathogenesis of ALD. Accumulating evidence has re-
vealed that gut microbiota is closely associated with liver
in ALD as the gut-liver axis [6, 7]. Impairment of gut
microbiota homeostasis in ALD induces proliferation of
gram negative pathogenic bacteria, which generate lipo-
polysaccharide (LPS) and translocate to liver tissue as a
trigger for hepatitis by binding to TLR-4 (Toll-like
receptor-4) on macrophages and neutrophils. Moreover,
Campos Canesso et al. showed that the administration
of alcohol to germ-free mice is associated to the absence
of liver inflammation and injury, indicating that alcohol
alone is not sufficient for the development of liver dis-
ease, and that the presence of microbiota alterations is
also necessary [8]. Thus, modulation of gut microbiota
dysbiosis could attenuate hepatic injury in ALD [3, 9].
Flaxseed oil (FO) is rich in plant-derived omega-3 (n-3)
polyunsaturated fatty acids (PUFAs), mainly α-linolenic acid
(ALA, 18:3 n-3). Clinical studies reported that a low levels
of n-3PUFAs in serum and liver tissue is a common charac-
teristic of ALD patients [10, 11]. Dietary FO prevented
against acute alcoholic hepatic steatosis via ameliorating
lipid homeostasis at adipose tissue-liver axis in mice [11].
However, the impact of dietary FO on inflammation and
gut micorbiota in chronic ALD remains unknown.
In the present study, we assessed effects of dietary FO
on attenuation of ALD and associated mechanisms in
mice. Results of the study may contribute to understand-
ing the role played by FO in ALD and the complexity of




Sixty male C57BL/6 J mice (8 weeks old) were obtained
from Vital River Laboratory Animal Technology Co. Ltd.,
Beijing, China. The animals were housed in individual
cages in a temperature-controlled (22 ± 1 °C), light-cycled
(12-h light/dark cycle) room.
All liquid diets for mice feeding were purchased
from TROPHIC Animal Feed High-tech Co., Ltd.,
Nantong, China.
Experimental design
After an 1-week period of acclimation to the control liquid
diet, maleC57BL/6 J mice (n = 60, 8 weeks old) were fed
the modified Lieber-DeCarli liquid diets as previously de-
scribed [11]. Briefly, mice were randomly allocated into
four groups (15 animals/group): (a) pair-fed (PF) with corn
oil (CO) group (PF/CO), mice were fed modified Lieber-
DeCarli CO liquid diets containing isocaloric maltose dex-
trin as CO control; (b) alcohol-fed (AF) with CO group
(AF/CO), mice were fed ethanol-containing modified
Lieber-DeCarli CO liquid diets; (c) PF with flaxseed oil
(FO) group (PF/FO), mice were fed modified Lieber-
DeCarli FO liquid diets containing isocaloric maltose dex-
trin as FO control; (d) AF with FO group (AF/FO), mice
were fed ethanol-containing modified Lieber-DeCarli FO
liquid diets. Mice in AF groups were fed the modified
Lieber-DeCarli liquid diets containing ethanol with an en-
ergy composition of 18% protein, 19% carbohydrate, 35%
fat and 28% ethanol, whereas animals in the PF groups
were fed the modified Lieber-DeCarli liquid diets, in
which, isocaloric maltose dextrin (carbohydrate) replaced
ethanol, and 35% of the total calories were provided by ei-
ther corn oil (rich in n-6 PUFAs) or flaxseed oil (rich in n-
3 PUFAs). Components of the liquid diets and the fatty
acid composition of dietary fats are shown in Add-
itional file 1 (Table S1) and Additional file 2 (Table S2),
respectively. Groups (a) and (c) were the pair-fed con-
trols for groups (b) and (d), respectively. Liquid diets
were freshly prepared from powder daily according to
the manufacturer’s instruction. Average daily volume of
liquid intake per mouse was monitored and calculated
in AF groups. Mice in PF groups consume equal
amounts of diets. After 6 weeks of feeding, mice were
then euthanized and associated indications were inves-
tigated. Blood samples were collected in ethylene di-
amine tetraacetic acid (EDTA)-containing tubes and
centrifuged (1200 × g for 15 min) to obtain plasma sam-
ples. All plasma samples were stored at −80 °C for fur-
ther analysis.
Determination of plasma AST and ALT levels
As biochemical indicators of liver function, plasma aspar-
tate aminotransferase (AST) and alanine aminotransferase
(ALT) activities in each group were respectively deter-
mined using AU400 automatic biochemical analyzer
(Olympus, Japan).
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Determination of plasma endotoxin
Plasma LPS levels in each mouse/group were measured
with limulus amebocyte lysate kit (Xiamen Bioendo
Technology Co.Ltd, Xiamen, China) according to the
manufacturer’s instructions.
HE staining
After mice sacrifice, liver tissues were immediately fixed
with formalin and processed with hematoxylin-eosin (HE)
staining to evaluate liver damage including hepatocyte fatty
change, inflammatory cells, degeneration and necrosis.
ELISA assays
Liver tissues (0.5 g) were homogenized in 1.5 ml ice-cold
50 mM Tris buffer (pH7.2, Tris with 1% Triton-X 100 and
0.1% protease inhibitor) and shaken on ice for 90 min.
Then the homogenates were centrifuged at 3,000 × g for
15 min. Supernatants were collected for determination of
tumor necrosis factor (TNF)-α, IL (interleukin)-1β, IL-6
and IL-10 concentrations. Measurements of each cytokine
level in plasma or the supernatants of liver tissues were
performed by enzyme linked immunosorbent assay
(ELISA) according to the manufacturer’s instructions
(e-Bioscience, CA, USA).
Gut microbiota analysis
The fecal microbial 16S rRNA gene sequencing and ana-
lysis were investigated as previously described [12]. After
6 weeks feeding, five mice per group were randomly se-
lected and transferred to fresh sterilized cages. The fresh
feces of each mouse was respectively collected, immedi-
ately frozen in liquid nitrogen, and then stored at −80 °C
until DNA extraction.
Microbial DNA was extracted from 200 mg feces sam-
ples as previously described [13]. Briefly, this sample
(200 mg) was resuspended in 4 ml of 4 M guanidine
thiocyanate–0.1 M Tris (pH7.5) and 600 μl of 10% N-
lauroyl sarcosine. The feces was ground with a mortar
on ice, 250 μg of the ground material was transferred to
a 2-ml screw-cap polypropylene microcentrifuge tube,
and the remaining material was frozen. After addition of
500 μl of 5% N-lauroyl sarcosine 0.1 M phosphate buffer
(pH8.0), the 2 ml tube was incubated at 70 °C for 1 h.
One volume (750 μl) of 0.1 mm diameter silica beads
(Sigma) previously sterilized by autoclaving was added,
and the tube was shakenat maximum speed for 10 min
in a Vibro shaker (Retsch). Polyvinylpolypyrrolidone
(15 mg) was added to the tube, which was vortexed and
centrifuged for 3 min at 12,000 × g. After recovery of the
supernatant, the pellet was washed with 500 μl of TENP
(50 mM Tris [pH8], 20 mM EDTA [pH8], 100 mM
NaCl, 1% polyvinylpolypyrrolidone) and centrifuged for
3 min at 12,000 × g, and the new supernatant was added
to the first supernatant. The washing step was repeated
three times. Pooled supernatants (about 2 ml) were
briefly centrifuged to remove particles and then split
into two 2 ml tubes. Nucleic acids were precipitated by
the addition of 1 volume of isopropanol for 10 min at
room temperature and centrifuged for 15 min at
20,000 × g. Pellets were resuspended and pooled in
450 μl of 100 mM phosphate buffer (pH8) and 50 μl of
5 M potassium acetate. The tube was placed on ice for
90 min and centrifuged at 16,000× g for 30 min. The
supernatant was transferred to a new tube containing
20 μl of RNase (1 mg/ml) and incubated at 37 °C for
30 min. Nucleic acids were precipitated by addition of
50 μl of 3 M sodium acetate and 1 ml of absolute ethanol.
The tube was incubated for 10 min at room temperature,
and nucleic acids were recovered by centrifugation at
20,000 × g for 15 min. The DNA pellet was finally
washed with 70% ethanol, dried, and resuspended in
400 μl TE buffer. DNA concentration and purity were
analyzed by Nanodrop (Thermo). Size distribution
(predominantly around 20 kb) were estimated by elec-
trophoresis (Additional file 3: Figure S1). Extracted
DNA was stored at −20 °C until use.
Sequences involving V3 and V4 16S rDNA hypervari-
able regions were amplified by TranStart FastPfu DNA
Polymerase (TransGen Biotech, China) using the follow-
ing primers (5’ to 3’): 341 F-CCTACGGGNGGCWGCAG,
805R-GACTACHVGGGTATCTAATCC. PCR products
were analyzed and separated by electrophoresis on 2%
agarose gel (containing SYB green), then purified with
Qiagen Gel Extraction Kit (Qiagen, Germany). Sequencing
libraries were generated using TruSeq DNA PCR manu-
facturer’s instructions and index codes were added. The li-
brary was sequenced and analyzed using an Illumina
HisSeq2500 platform by Shanghai Tai Chang gene tech-
nology co., LTD., China
Statistical analysis
All data were analyzed using Prism 5.0 (GraphPad Soft-
ware Inc., CA, USA). Results were represented as mean ±
SEM. Two-way analysis of variance (ANOVA) followed by
the Turkey multiple-comparison test was used to deter-
mine statistical difference between experimental groups.
Results were considered significant at P < 0.05.
Results
Routine parameters of mice in diverse dietary groups
There was no significant difference in initial body weight
(BW) among four groups. However, after 6 weeks feeding,
the final BW in AF/CO group was significantly decreased,
compared with that in paired PF/CO group (P < 0.01) or
AF/FO group (P < 0.01). The final BW in AF/FO showed
no change compared with PF/FO. These results demon-
strated that flaxseed oil maintained the BW during
chronic ethanol feeding. Liver weight in AF group (AF/
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CO group and AF/FO group) was significantly elevated
comparing to that in PF group (PF/CO group and PF/FO
group) (Table 1). Similarly, the ratio of liver-to-body
weight in alcohol exposure group regardless of dietary fat
was significantly increased compared with that in no etha-
nol pair-fed group. In addition, the plasma AST and ALT
levels in AF/CO group were significantly elevated by 2.5-
fold (185.9 ± 13.3 vs. 74.8 ± 8.6) and 2-fold (104.8 ± 11.4
vs. 52.6 ± 5.9) compared with that in pair-fed PO/CO
group, respectively. However, these AST and ALT eleva-
tions in AF/CO group were effectively suppressed by diet-
ary FO administration in AF/FO group (185.9 ± 13.3 vs.
109.7 ± 7.2, 104.8 ± 11.4 vs. 75.2 ± 6.1) (Table 1).
Dietary FO attenuated hepatic histopathological injury
and reduced plasma LPS levels
According to HE staining for liver in diverse groups, hep-
atic fatty change, necrosis and inflammation were serious
in chronic alcohol feeding group (AF/CO), whereas long-
term dietary FO distinctly alleviated the alcohol-induced
hepatic histopathological injury (Fig. 1a).
Plasma LPS in AF/FO group was significantly de-
creased compared with AF/CO group (P < 0.0001), but
still higher than PF/CO or PF/FO group (Fig. 1b), dem-
onstrating that dietary FO possessed ability to attenuated
LPS generation from Gram-negative pathogenic bacteria.
Dietary FO reduced plasma inflammatory cytokine levels
in ALD
After chronic ethanol feeding, we found obvious elevated
plasma TNF-α, IL-1β, IL-6 and IL-10 in AF/CO and AF/
FO groups compared with these cytokines in pair-fed group
(Fig. 2). However, dietary FO attenuated ethanol-inducing
abnormal elevated TNF-α concentration, compared with
that in PF control group (P = 0.0095, Fig. 2a). Similarly,
plasma IL-1β (P = 0.007, Fig. 2b) and IL-6 (P < 0.0001,
Fig. 2c) levels in AF/FO were also significantly reduced in
comparison with those two cytokines in AF/CO group. It
showed no significant difference in plasma IL-10 level be-
tween AF/CO and AF/FO groups (P = 0.3229, Fig. 2d).
Dietary FO reduced liver inflammatory cytokine levels in
ALD
We detected the cytokine production in liver tissue
and also found elevated TNF-α, IL-1β, IL-6 and IL-10
in AF group compared with PF group. Similarly, TNF-
α (p < 0.001, Fig. 3a), IL-1β (P = 0.0021, Fig. 3b) and
IL-6 (P = 0.0022, Fig. 3c) levels in AF/FO group were sig-
nificantly decreased compared with those three cytokines
in AF/CO group. It showed also no significant difference
in IL-10 level in supplementary FO group during chronic
ethanol feeding (P = 0.1635, Fig. 3d).
Dietary FO modulated gut microbiota in ALD
Gut microbiota have been increasingly thought to play a
critical role in ALD development in mice and humans
[3, 14–18]. To investigate whether the observed differ-
ences in liver inflammation among AF/CO, AF/FO and
those PF groups were associated with the difference in
the intestinal microbiota, we performed fecal metage-
nomic analysis. Rationality of sequencing data was evalu-
ated by rarefaction curve (Additional file 4: Figure S2). It
was observed that the rarefaction curve tended to be flat
when the sequence number increased to 20,000, indicat-
ing that the amount of sequencing data was reasonable.
The overall bacterial community structure was analyzed
using unweighted UniFrac (Pcoa) (Fig. 4) and weighted dis-
tance matrices (NMDS) (Additional file 5: Figure S3). Pcoa
showed that chronic alcohol consumption induced an obvi-
ous difference in terms of species in fecal samples com-
pared with pair-fed control feeding (Fig. 4a and b). There’s
no obvious change in terms of species between AF/CO
group and AF/FO group (Fig. 4c). Interestingly, during nor-
mal liquid feeding, supplementary FO seemingly altered the
fecal species compared with CO feeding (Fig. 4d).
Similar results from NMDS analysis were obtained
(Additional file 5: Figure S3).
At phylum level, the proportion of Firmicutes was not-
ably increased in alcohol feeding groups compared with
those in the PF groups (P = 0.0159, Fig. 5a). Meanwhile,
there’s no change between AF/FO and AF/CO groups
(P = 0.8385, Fig. 5a). Bacteroidetes accounted for more
than half of proportion in diverse administration groups
Table 1 Routine parameters of mice in diverse dietary groups in ALD
Measurements PF/CO AF/CO PF/FO AF/FO Two-way ANOVA
Ethanol Oil Interaction
Body weight, g 26.15 ± 0.27 23.99 ± 0.29 26.34 ± 0.33 26.57 ± 0.28 <0.0001 0.0019 0.0002
Liver weight, g 0.89 ± 0.03 1.25 ± 0.04 1.00 ± 0.02 1.44 ± 0.04 <0.0001 <0.0001 0.2722
LW/BW, % 3.40 ± 0.11 5.21 ± 0.14 3.80 ± 0.06 5.42 ± 0.14 <0.0001 <0.0001 0.0027
AST, U/L 74.8 ± 8.6 185.9 ± 13.3 68.4 ± 6.7 109.7 ± 7.2 <0.0001 <0.0001 <0.0001
ALT, U/L 52.6 ± 5.9 104.8 ± 11.4 47.6 ± 8.2 75.2 ± 6.1 <0.0001 <0.0001 <0.0001
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and decreased in AF/CO group in comparison with
other three groups but with no significant difference.
The proportion of Proteobacteria showed no alteration
in chronic consumption of alcohol compared with non-
ethanol controls. The proportion of Proteobacteria in AF/
FO group was significantly lower than that in AF/CO
group (0.074 ± 0.009 vs. 0.117 ± 0.003, P < 0.0001) or PF/
FO group (0.074 ± 0.009 vs. 0.124 ± 0.009, P < 0.0001).
Taken together, our data revealed that under this experi-
mental condition a combination of ethanol and dietary FO
(AF/FO) had a major effect on Proteobacteria but with
limited effects on Bacteriodetes and Firmicutes.
At genus level, we found Porphyromonadaceae was
the most prevalent genus in the control groups (PF/CO
and PF/FO) and obviously reduced in dietary alcohol ad-
ministration groups (P < 0.0001, Fig. 5b). Moreover, the
proportion of Porphyromonadaceae in AF/FO group
showed lower than that in AF/CO group but without
significance (0.176 ± 0.026 vs. 0.146 ± 0.013, P = 0.0503).
In contrast, Parabacteroides was sharply elevated in the
AF) groups (AF/CO and AF/FO) compared with the
control groups (P = 0.0211, Fig. 5b). Additionally, Para-
sutterella was the second prevalent genus in each group.
Alcohol administration induced a significant reduction
of Parasutterella in comparison to that in the control
groups (P = 0.0005). Collectively, our genus results indi-
cating that chronic alcohol consumption obviously al-
tered the initial proportion of genus components, mainly
including Porphyromonadaceae, Parabacteroides and
Parasutterella.
Furthermore, heatmap also showed that dietary FO
(AF/FO) had a major effect on Proteobacteria, with
Fig. 2 Detection of plasma inflammatory cytokine levels from diverse groups in mice. Plasma of mice from diverse groups were collected respectively for
detection of TNF-α (a), IL-1β (b), IL-6 (c) and IL-10 (d) concentrations using ELISA kit. Data are expressed as mean ± SEM.*P< 0.05, **P< 0.001, ***P< 0.0001
Fig. 1 Effects of different dietary oil profile on liver injury and endotoxemia
in ALD. a: Representative images of hepatic hemaatoxylin and eosin (H&E)
staining. b: Plasma lipopolysaccharide (LPS) levels. Data are expressed as
mean± SEM. *P<0.05, **P<0.001, ***P<0.0001. Original magnification,
×200 (A). CV, central vein; F, fatty change; IC, inflammatory cells
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Fig. 4 PcoA analysis showing difference in terms of species in fecal samples. Beta diversity was on weighted UniFrac. a: PF/CO vs. AF/CO; b: PF/
CO vs. PF/FO; c: AF/CO vs. AF/FO; d: PF/FO vs. AF/FO
Fig. 3 Detection of hepatic inflammatory cytokine levels from diverse groups in mice. Liver tissue of mice from diverse groups were collected
respectively for detection of TNF-α (a), IL-1β (b), IL-6 (c) and IL-10 (d) concentrations using ELISA kit. Data are expressed as mean ± SEM.*P < 0.05,
**P < 0.001, ***P < 0.0001
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limited effects on Bacteriodetes and Firmicutes. More-
over, many other tiny bacteria showed obvious difference
between AF and PF groups, such as Barnesiella, Psychro-
bacter, Deltaproteobacteria, Acinetobacter, Flavonifractor,
and Lactococcus (Fig. 6a). However, diverse dietary oil had
a less effect of on the influence of these seldom bacteria
proportion (Fig. 6b).
Discussion
In the present study, we investigated the efficacy of
long-term dietary FO for chronic ALD. By in vivo 6-
weeks treatment of ALD in mice, our study demon-
strated that supplementary FO showed more effective in
reduction of hepatic damage, suggesting that this inex-
pensive interventions exhibited preventive and thera-
peutic potential. Our further study revealed that this
effective treatment may associated with altered gut
microbiota and the decrease of liver inflammation.
Numerous studies indicated that alcohol exposure sig-
nificantly reduced final BW in chronic ALD [3, 9, 11, 19].
In this study, we also found that BW was lower in AF/CO
group, although the caloric intake was identical among all
groups. Dietary FO efficiently improved the final BW in
ALD compared with AF/CO, indicating that FO may
positively affect nutrients absorption and efficiency of
calorie utilization in gastrointestinal tract in ALD. Liver
weight and relative liver weights in AF group regardless
of dietary oil significantly increased, which was consist-
ent with previous reports [9], suggesting that substitut-
ing FO for CO in chronic ethanol intake had no effect
on liver weight.
In this study, we found abnormal elevated plasma ALT
and AST levels in AF/CO group, indicating alcohol
induced liver injury [9]. Significant reductions of plasma
ALT and AST in AF/FO group revealed that supplemen-
tary FO alleviated liver damage caused by chronic etha-
nol feeding. Similarly, dietary fish oil, rich in long-chain
n-3 polyunsaturated fatty acids, mainly eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), has
showed also the ability to attenuate liver injury by redu-
cing ALT and AST levels in ALD [9, 17]. Inexpensive
dietary FO-derived ALA, served as a precursor for the
synthesis of EPA and DHA, can converse to EPA and
DHA in the blood and tissues [20].
LPS, a trigger for hepatic inflammation in ALD, translo-
cates to liver via portal vein and binds to TLR-4 of antigen
presenting cells (APCs) to induce inflammatory immune
response and finally cause chronic hepatitis [21, 22]. In
this study, plasma LPS in AF/FO group was obviously de-
creased, demonstrating that dietary FO may decrease gut
permeability and reduce LPS translocation from intestines
to the liver and systematic circulation in ALD, which con-
tributed to the reduction of inflammatory response in the
liver. This attenuation may be associated with intestinal
innate immune system and the underlying mechanism
needs to be further researched [23].
Activation of Kupffer cells and neutrophils induces oxi-
dative stress and produces inflammatory cytokines, such
as TNF-α, IL-1β and IL-6 that cause apoptosis and necro-
sis of hepatocytes and consequently result in liver injury
[9, 24, 25]. Our results showed that TNF-α, IL-1β and IL-
6 levels of plasma and liver tissue in AF/FO group were
significantly decreased, demonstrating that dietary FO al-
leviated hepatic inflammation via anti-inflammatory cyto-
kines. IL-10 is an anti-inflammatory cytokine released by
Kupffer cells and monocytes [26, 27]. But in this study, we
Fig. 5 Relative abundance of microbial species at the phylum and genus levels in the feces of mice. a: The phylum analysis; b: The genus analysis
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found IL-10 showed no difference among all groups,
which was not paralleled with previous study [9]. We spec-
ulated that IL-10 maybe play a complicated role in imbal-
ance between regulation of pro- and anti- inflammatory
mediators during chronic ethanol exposure. Additionally,
regulatory immune cells especially regulatory T lympho-
cytes (Tregs) [28], which play a critical role in regulation of
proinflammation to keep maintain immune balance in
ALD [29, 30], need to be investigated in our further study.
Gut micobiota dysbiosis is thought to play a crucial
role in the pathogenesis of ALD [6, 31, 32]. In this study,
at phylum level, Bacteriodetes and Firmicutes were the
most dominant in all four groups, which were paralleled
with previous studies [12, 33]. The proportion of Firmi-
cutes was notably increased in alcohol feeding groups com-
pared with the PF groups, which were in agreement with
previous studies [3, 32]. Our results showed decreased Bac-
teriodetesand higher Proteobacteriain alcohol intake group
(AF/CO), which were responsible for gut dysbiosis as re-
cently described in human and animal studies [3, 18]. Im-
portantly, dietary FO notably reduced the proportion of
Proteobacteria in chronic alcohol consumption, revealing
that dietary FO may attenuate gut dysbiosis presumably by
modulating gut Proteobacteria. Exact mechanism(s) under-
lying these effects remain to be determined.
At the genus level, decreased gut Porphyromonadaceae
and inversely elevated Parabacteroides were found in
chronic alcohol administration. Porphyromonadaceae was
negatively correlated with TNF-α expression in the liver in
ALD [34], which was paralleled with our result and the de-
crease of gut Porphyromonadaceae may benefit for aggrava-
tion of the liver inflammation. Elevated Parabacteroidesin
AF/FO group was also involved in the prevention of hepatic
inflammation in ALD as previously described [34]. Our re-
sults showed that alcohol administration induced a signifi-
cant reduction of Parasutterella in comparison to the
control groups. The physiological role of Parasutterella is
much less understood. Taken together, the exact role of
microbiota is complicated and still largely unknown.
Conclusions
This study highlighted that dietary FO ameliorates alco-
holic liver disease via anti-inflammation and modulating
gut microbiota in mice, suggesting that it can potentially
serve as inexpensive interventions for the prevention
and treatment of ALD.
Fig. 6 Heatmap analysis of microbial community composition in the feces of mice. a: alcohol-fed (AF) vs. pair-fed (PF); b: flaxseed oil
(FO) vs. corn oil (CO)
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Additional files
Additional file 1: Table S1. Compositions of the modified Lieber-
DeCarli liquid diets. PF/CO, pair-fed with corn oil; AF/CO, alcohol-fed with
corn oil; PF/FO, pair-fed with flaxseed oil; AF/FO, alcohol-fed with flaxseed
oil (DOCX 12 kb)
Additional file 2: Table S2. Fatty acid composition (%) of dietary fats
contained in liquid diets. (DOCX 12 kb)
Additional file 3: Figure S1. Size distribution (predominantly around
20 kb) was estimated by electrophoresis. (DOCX 62 kb)
Additional file 4: Figure S2. Rationality of sequencing data was evaluated
by rarefaction curve. It was observed that the rarefaction curve tended to be
flat when the sequence number increased to 20,000, indicating that the
amount of sequencing data was reasonable. (DOCX 115 kb)
Additional file 5: Figure S3. NMDS analysis showed the difference in
terms of species in fecal samples. Beta diversity was analyzed on
unweighted Unifrac. A: PF/CO vs. AF/CO; B: PF/CO vs. AF/FO; C: AF/CO vs.
AF/FO; D: PF/CO vs. PF/FO. (DOCX 136 kb)
Additional file 6: Datasets for Figures S1-S6. (ZIP 258 kb)
Abbreviations
AF: Alcohol-fed; ALA: α-linolenic acid; ALD: Alcoholic liver disease;
ALT: Alanine aminotransferase; APCs: Antigen presenting cells; AST: Aspartate
aminotransferase; BW: Body weight; CO: Corn oil; DHA: Docosahexaenoic
acid; EDTA: Ethylene diamine tetraacetic acid; ELISA: Enzyme linked
immunosorbent assay; EPA: Eicosapentaenoic acid; FO: Flaxseed oil;
HE: Hematoxylin-eosin; IL: Interleukin; LPS: Lipopolysaccharide; PF: Pair-fed;
PUFA: Polyunsaturated fatty acids; TLR-4: Toll-like receptor-4; TNF-α: Tumor
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